Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 3,864,184 $ 4,399,726
Short-term investment 4,000,000
Interest receivable 53,082
Prepaid expenses and other current assets 1,628,317 1,614,956
Total current assets 5,492,501 10,067,764
Total assets 5,492,501 10,067,764
Current liabilities:    
Accounts payable and accrued expenses 1,821,867 1,559,011
Short-term notes payable, net of debt issuance costs 227,348
Total liabilities 1,821,867 1,786,359
Stockholders’ equity:    
Preferred stock, no par value; 50,000,000 shares authorized; 424,533 Series H and 7,488,692 Series F outstanding at June 30, 2026, and 429,291 Series H and 7,488,692 Series F outstanding at December 31, 2025.
Common stock, $0.001 par value; 350,000,000 shares authorized; 4,511,957 and 4,271,529 shares issued and outstanding at June 30, 2026, and December 31, 2025, respectively 4,512 4,271
Additional paid-in capital 235,024,731 234,905,793
Accumulated deficit (231,358,609) (226,628,659)
Total stockholders’ equity 3,670,634 8,281,405
Total liabilities and stockholders’ equity $ 5,492,501 $ 10,067,764